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Abstract
Background: Healthy Living after Cancer (HLaC) was a national dissemination and implementation study of an
evidence-based lifestyle intervention for cancer survivors. The program was imbedded into existing telephone
cancer information and support services delivered by Australian state-based Cancer Councils (CC). We report here
the reach, effectiveness, adoption, implementation, and maintenance of the program.
Methods: In this phase IV study (single-group, pre-post design) participants - survivors of any type of
cancer, following treatment with curative intent - received up to 12 nurse/allied health professional-led
telephone health coaching calls over 6 months. Intervention delivery was grounded in motivational
interviewing, with emphasis on evidence-based behaviour change strategies. Using the RE-AIM evaluation
framework, primary outcomes were reach, indicators of program adoption, implementation, costs and
maintenance. Secondary (effectiveness) outcomes were participant-reported anthropometric, behavioural and
psychosocial variables including: weight; physical activity; dietary intake; quality-of-life; treatment side-effects;
distress; and fear of cancer recurrence and participant satisfaction. Changes were evaluated using linear
mixed models, including terms for timepoint (0/6 months), strata (Cancer Council), and timepoint x strata.
Results: Four of 5 CCs approached participated in the study. In total, 1183 cancer survivors were referred
(mostly via calls to the Cancer Council telephone information service). Of these, 90.4% were eligible and
88.7% (n = 791) of those eligible consented to participate. Retention rate was 63.4%. Participants were
mostly female (88%), aged 57 years and were overweight (BMI = 28.8 ± 6.5 kg/m2). Improvements in all
participant-reported outcomes (standardised effect sizes of 0.1 to 0.6) were observed (p < 0.001). The
program delivery costs were on average AU$427 (US$296) per referred cancer survivor.
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Conclusions: This telephone-delivered lifestyle intervention, which was feasibly implemented by Cancer
Councils, led to meaningful and statistically significant improvements in cancer survivors’ health and quality-
of-life at a relatively low cost.
Trial registration: Australian and New Zealand Clinical Trials Registry (ANZCTR) - ACTRN12615000882527
(registered on 24/08/2015).
Keywords: Lifestyle intervention, Cancer survivors, Dissemination and implementation study, Physical
activity, Nutrition, Healthy weight
Background
The number of cancer survivors is rapidly increasing
worldwide [1]. This is largely due to improved screening
and treatments leading to increased survival rates for the
majority of cancers. In Australia, survival rates continue
to improve, with 5-year survival for all cancers at 69%
for the period 2011–2015 (up from 50% in 1986–1990)
and over 90% for some cancers, such as prostate (95%)
and breast cancer (91%) [2]. While a highly positive
trend, longer cancer survivorship also results in higher
risk of certain adverse outcomes, including cancer recur-
rence, second primaries, persistent side-effects of treat-
ment, functional decline and co-morbid chronic
conditions, such as cardiovascular disease and type 2
diabetes [3–6]. Engagement in regular physical activity,
improvement in diet and keeping within a healthy weight
range are recognised as evidence-based methods of miti-
gating these long-term risks and are recommended by
most national cancer organisations [7–9]. These recom-
mendations are supported by a strong body of evidence
showing they lead to improved survivorship outcomes;
yet, adherence to these recommendations is poor [10].
More than half of cancer survivors are overweight or
obese, more than half do not meet physical activity recom-
mendations, and two-thirds do not meet dietary guidelines
[11]. Following cancer treatment, declines in activity and
weight gain are also common [12–14]. While most cancer
survivors desire guidance regarding healthy lifestyles [15,
16], and there is increased recognition of the importance
of improving healthy lifestyle behaviours in models of sur-
vivorship care [17], cancer care does not routinely include
such assistance [15, 18, 19].
A large body of research, as summarised in systematic
reviews and meta-analyses [20–22] has demonstrated
that lifestyle interventions are efficacious in improving a
range of behavioural and clinical outcomes in survivors
of various cancers. The evidence is strongest in women
with breast cancer and for physical activity interventions
[23], but there is also evidence for the benefits accrued
from dietary interventions [24] and for weight loss inter-
ventions [25]. These interventions have also been shown
to have a maintenance effect at least 3 months post-
intervention completion [26]. Given the strength of
evidence, the focus of more recent research has turned
toward the evaluation of broad-reach or distance inter-
vention modalities, particularly those that are telephone-
based, in order to understand if this delivery mode has
the potential for greater reach than face-to-face inter-
ventions, while maintaining effectiveness [27–29]. A sys-
tematic review of 27 trials of broad-reach lifestyle
interventions among cancer survivors, where 22 were based
on telephone delivery, indeed found evidence for improve-
ments in lifestyle behaviours and weight loss across cancer
survivor groups [30]. Another study, which compared the ef-
fectiveness of a telephone versus face-to-face delivered inter-
vention for achieving improvements in fitness and quality of
life in women treated for breast cancer, found the two mo-
dalities did not differ in effectiveness [31, 32]. Importantly,
the study concluded that telephone-based interventions are
considered suitable for reaching women living in regional
and rural Australia [33]. This large body of evidence supports
the present study.
The Healthy Living after Cancer (HLaC) Partnership
Project is a dissemination and implementation trial
evaluating the effect of a 6-month, telephone-based
lifestyle intervention for cancer survivors delivered by
four Australian state-based Cancer Councils (non-gov-
ernment organisations) as part of their Cancer Infor-
mation and Support Service. The Cancer Councils
were highly aligned partners for this work in that:
they each had a mandate to provide survivorship ser-
vices on a state-wide basis, noting that 30% of Aus-
tralians with cancer live outside of metropolitan areas
[34]; and they had the telephonic infrastructure and
staff to implement the project. The RE-AIM frame-
work (reach, effectiveness, adoption, implementation,
maintenance) [35] is used for evaluation as its em-
phasis on indicators of both internal validity (effect-
iveness) and external validity (implementation) is
aligned to the dissemination context of the study. We
report on primary outcomes (program adoption,
reach, implementation, costs and maintenance) and
secondary (effectiveness) outcomes including an-
thropometric, behavioural and psychosocial changes
from pre – (baseline) to post - (6 month) program
and participant satisfaction.
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Methods
Study design
Detailed methods for the HLaC study have been previ-
ously reported [36]. The study received ethical approval
from: The University of Queensland, Cancer Council
Victoria (on behalf of Cancer Councils Victoria and
South Australia), Cancer Council New South Wales, and
the University of Western Australia (on behalf of Cancer
Council Western Australia).
Participants and recruitment
Participants were referred to the program between June
2015 and September 2018 (see Fig. 1). Inclusion criteria
were designed to be as broad as possible, thereby maxi-
mising the diversity of survivors able to take part safely.
The eligibility criteria were:
Adults (18+ years); diagnosed with a cancer of any
type that was localised, non-metastatic and treated with
curative intent;
Completed primary treatment (ongoing hormonal
treatment or trastuzumab was permitted);
No contraindications to engaging in unsupervised
physical activity, including but not limited to: active
heart disease, breathing problems, planned knee or hip
replacement, pregnant or intending to become
pregnant in the next 6 months;
No cognitive or mental health impairments that
would hinder program participation;
Sufficiently proficient in the English language to
meaningfully participate in the program;
Wanting support for healthy living via physical
activity and healthy eating and willing to make a six-
month commitment to program participation.
Participant eligibility was self-reported to Cancer
Council staff who conducted screening over the tele-
phone using a recruitment and screening script (refer to
Table 1 in published protocol paper [36]). In cases where
eligibility was uncertain, clearance was sought from the
participants treating clinician.
Healthy living after Cancer program
A detailed description of the HLaC program is provided
elsewhere [36]. Briefly, the intervention was based on
Social Cognitive Theory constructs including self-
efficacy, social support and outcome expectancies [37]
and guided by techniques of motivational interviewing
[38] and health behaviour coaching [39]. The program
was aimed at increasing physical activity, promoting
healthy eating, and assisting with moderate weight loss
(if indicated), consistent with current evidence and
guidelines for nutrition and physical activity in cancer
survivors [7–9]. Participants were encouraged to
consider making changes in all target areas (physical ac-
tivity, diet, weight loss), but were able to choose to focus
on one, two or all three domains. They received up to
12 coaching calls over the six-month program and a Par-
ticipant Workbook [36], and were guided to develop
skills in goal setting, self-monitoring, problem solving,
identifying social support, stimulus control, positive self-
talk and self-reward [40]. Cancer Council nurses/allied
health professionals were trained by lead study investiga-
tors in the intervention protocol during a two-day work-
shop and provided with a training manual containing
detailed call-by-call scripts and checklists. A lead nurse/
health professional at each Cancer Council was desig-
nated to train new staff in a train-the-trainer approach.
To address fidelity of intervention delivery during the
first 2 years of the program, intervention calls were voice
recorded approximately monthly for feedback and
monthly case teleconferences were held.
Data collection
Data were collected at baseline and six-months (post-
program; primary endpoint) by study-trained Cancer
Council staff using validated questionnaires [36].
Monthly database reports submitted by Cancer Council
staff to the research team were used to monitor protocol
implementation and data quality.
Primary outcomes
Primary outcomes were mapped to the RE-AIM frame-
work [35].
Reach: number of referrals and referral source; pro-
gram uptake, participant characteristics.
Implementation: study retention, program completion
and call delivery (number and duration of calls) and ad-
verse events.
A serious adverse events protocol required Cancer
Council staff to report these to study investigators within
24 h. Events were classified by investigators as severe/un-
desirable (significant symptoms requiring hospitalisation
or invasive intervention), life threatening / disabling
(acute, life-threatening complication or consequences),
or fatal (death related to serious adverse event).
Costs: Costs of program delivery are reported with the
methodology described in Additional file 1.
Maintenance: is reported as the number of Cancer
Councils continuing or discontinuing HLaC following
the end of the study.
Secondary outcomes (effectiveness)
Secondary outcomes were all self-reported and mostly
assessed using measures validated for use with cancer
populations [36].
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Anthropometric measures were weight (kg and
body mass index BMI [weight in kg / height in m2])
and waist circumference (cm).
Time spent in moderate-vigorous physical activity
(MVPA; min/week) was collected using the Active
Australia Survey [41] using standard scoring (i.e.,
truncating individual items at 840 min and the total
score [walking time, other moderate activity time ex-
cluding gardening, and 2 x vigorous activity time] at
1680 min). Sitting time (hours/day) was assessed
Fig. 1 HLaC participant flowchart
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Table 1 Baseline Characteristics of Healthy Living After Cancer (HLaC) participants overall and by Cancer Council
Overall Overall A B C D p a
n Summary n Summary n Summary n Summary n Summary











Male 94 12.0% 32 12.9% 16 9.4% 29 14.5% 17 10.1% 0.384
Female 692 88.0% 216 87.1% 154 90.6% 171 85.5% 151 89.9%
Ethnicity 0.006 b
Aboriginal or Torres Strait Islander 7 0.9% 5 2.0% 1 0.6% 1 0.5% 0 0.0%
Asian 39 5.0% 14 5.6% 3 1.8% 13 6.5% 9 5.4%
Caucasian or white 705 89.7% 212 85.5% 162 95.3% 179 89.50% 152 90.5%
Middle Eastern 9 1.1% 3 1.2% 2 1.2% 3 1.5% 1 0.6%
Pacific Islander 7 0.9% 5 2.0% 0 0.0% 0 0.0% 2 1.2%
South American 7 0.9% 5 2.0% 0 0.0% 1 0.5% 1 0.6%
Other 10 1.3% 3 1.2% 1 0.6% 3 1.5% 3 1.8%
Not reported 2 0.3% 1 0.4% 1 0.6% 0 0.0% 0 0.0%
Comorbidities
0 160 20.4% 61 24.6% 29 17.1% 44 22.0% 26 15.5% 0.005
1 189 24.0% 68 27.4% 38 22.4% 48 24.0% 35 20.8%
2 160 20.4% 46 18.5% 41 24.1% 40 20.0% 33 19.6%
3 123 15.6% 28 11.3% 30 17.6% 34 17.0% 31 18.5%
≥ 4 154 19.6% 45 18.1% 32 18.8% 34 17.0% 43 25.6%
Education
< High School 115 14.6% 34 13.7% 33 19.4% 31 15.4% 17 10.1% 0.004
High School 71 9.0% 16 6.5% 24 14.1% 19 9.5% 12 7.1%
TAFE / Technical 267 34.0% 72 29.0% 57 33.5% 69 34.5% 69 41.1%
University 333 42.4% 126 50.8% 56 32.9% 81 40.5% 70 41.7%
BMI, kg/m2 M ± SD 786 28.81 ± 6.51 248 27.67 ± 6.47 170 30.14 ± 6.52 200 29.05 ± 6.28 168 28.85 ± 6.59 0.002
Employment
Full time 149 19.0% 48 19.4% 25 14.7% 44 22.0% 32 19.0% 0.261
Part-time / Casual 231 29.4% 69 27.8% 50 29.4% 61 30.5% 51 30.4%
Self employed 13 1.7% 4 1.6% 1 0.6% 5 2.5% 3 1.8%
Home duties 62 7.9% 21 8.5% 14 8.2% 15 7.5% 12 7.1%
Retired 164 20.9% 57 23.0% 29 17.1% 34 17.0% 44 26.2%
Unable to work 104 13.2% 32 12.9% 34 20.0% 24 12.0% 14 8.3%
Other not working 63 8.0% 17 6.9% 17 10.0% 17 8.5% 12 7.1%
Alcohol (standard drinks/ week) c
0 390 49.6% 120 48.4% 81 47.6% 101 50.5% 88 52.4% 0.867
> 0 to < 21 370 47.1% 118 47.6% 82 48.2% 96 48.0% 74 44.0%
21 to < 35 21 2.7% 8 3.2% 6 3.5% 2 1.0% 5 3.0%
≥ 35 5 0.6% 2 0.8% 1 0.6% 1 0.5% 1 0.6%
Marital status
Married / living together 501 63.7% 160 64.5% 109 64.1% 120 60.0% 112 66.7% 0.681
Divorced 124 15.8% 34 13.7% 30 17.6% 32 16.0% 28 16.7%
Separated 31 3.9% 14 5.6% 4 2.4% 7 3.5% 6 3.6%
Widowed 34 4.3% 13 5.2% 6 3.5% 10 5.0% 5 3.0%
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using the Active Australia Survey [41] weekday sit-
ting item.
Daily serves of fruit and vegetables were assessed using
National Health Survey items [42].
A Fat Index and Fibre Index (scored 1–5, with higher values
indicating healthier behaviours) was obtained using the vali-
dated 20-item Fat and Fibre Behaviour Questionnaire [43].
Quality of life was assessed using the Physical and Men-
tal Components Scores of the Short-Form Health Survey
SF-12, V1 with Australian weightings [44], for which
higher values indicate better quality of life. To minimise
unnecessary data loss and potential bias from non-
reporting of a small number of items, up to three missing
items, replaced by their group mean, were permitted [45].
Table 1 Baseline Characteristics of Healthy Living After Cancer (HLaC) participants overall and by Cancer Council (Continued)
Overall Overall A B C D p a
n Summary n Summary n Summary n Summary n Summary
Never married 96 12.2% 27 10.9% 21 12.4% 31 15.5% 17 10.1%
IRSAD
Bottom 30% of state 133 17.1% 35 14.1% 35 21.2% 40 20.0% 23 13.9% 0.268
Middle 40% of state 299 38.5% 93 38.0% 66 40.0% 77 38.5% 63 51.8%
Top 30% of state 344 44.3% 117 47.8% 64 38.8% 83 41.5% 80 48.2%
Missing 10 – 3 – 5 – 0 – 2 –
Geographic location
Major City 594 76.3% 198 80.8% 112 67.1% 149 74.5% 135 80.4% 0.005
Elsewhere 184 23.7% 47 19.2% 55 32.9% 51 25.5% 31 18.7%
Missing 8 – 3 – 3 – 0 – 2 –
Years since diagnosis: M ± SD, Median (min,
max)
786 1.91 ± 3.02 248 2.11 ± 2.72 170 1.86 ± 2.98 200 1.70 ± 1.95 168 1.92 ± 4.28 0.316
1 (0, 54) 1 (0, 20) 1 (0, 32) 1 (0, 15) 1 (0, 54)
Cancer type
Breast 484 61.6% 143 57.7% 113 66.5% 114 56.7% 114 67.9% 0.113 b
Cervical 12 1.5% 6 2.4% 1 0.6% 4 2.0% 1 0.6%
Colorectal / bowel 71 9.0% 18 7.3% 16 9.4% 22 11.0% 15 8.9%
Kidney 7 0.9% 2 0.8% 1 0.6% 4 2.0% 0 0.0%
Lung 7 0.9% 3 1.2% 0 0.0% 1 0.5% 3 1.8%
Lymphoma 66 8.4% 22 8.9% 15 8.8% 17 8.5% 12 7.1%
Melanoma 2 0.3% 0 0.0% 0 0.0% 1 0.5% 1 0.6%
Prostate 30 3.8% 11 4.4% 7 4.1% 5 2.5% 7 4.2%
Stomach 2 0.3% 0 0.0% 0 0.0% 2 1.0% 0 0.0%
Testicular 3 0.4% 0 0.0% 1 0.6% 2 1.0% 0 0.0%
Ovarian 19 2.4% 10 4.0% 4 2.4% 4 2.0% 1 0.6%
Uterine 15 1.9% 2 0.8% 2 1.2% 9 4.5% 2 1.2%
Endometrial 10 1.3% 5 2.0% 2 1.2% 2 1.0% 1 0.6%
Leukaemia 11 1.4% 5 2.0% 4 2.4% 2 1.0% 0 0.0%
Other 47 6.0% 21 8.5% 4 2.4% 11 5.5% 11 6.5%
Treatment
Surgery 686 87.3% 208 83.9% 147 86.5% 178 89.0% 153 91.1% 0.140
Chemotherapy 531 67.6% 166 66.9% 123 72.4% 128 64.0% 114 67.9% 0.389
Radiotherapy 469 59.7% 155 62.5% 103 60.6% 119 59.5% 92 54.8% 0.465
Hormone therapy 343 43.6% 105 42.3% 62 36.5% 92 46.0% 84 50.0% 0.073
trastuzumab 75 9.5% 19 7.7% 22 12.9% 13 6.5% 21 12.5% 0.069
IRSAD index of relative socioeconomic advantage and disadvantage, BMI body mass index
a p for difference between cancer council by ANOVA (M ± SD) or chi-square test (%)
b due to insufficient frequencies chi-square test based on collapsed categories: Caucasian / other; breast / colorectal or bowel / lymphoma / prostate / other
c Measured per week: cut-offs based on daily thresholds of none, > 0 to < 3/day, 3 to < 5 / day, and > =5 /day)
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Cancer and treatment-related symptoms and side ef-
fects were assessed using the Symptom Severity and
Symptom Interference scores of the MD Anderson
Symptom Inventory [46]. Ten core symptoms were
assessed: fatigue, sleep disturbance, distress, shortness of
breath, poor memory, poor appetite, drowsiness, sadness
and numbness; an average was then taken. Higher scores
(0–10) indicate greater severity or interference.
Fear of cancer recurrence was assessed using the 4-item
Concerns about Recurrence Questionnaire [47]. Scores
were calculated by summing four items, after first convert-
ing the 0–100% likelihood of recurrence item to the same
0–10 scale as the remaining items. Higher scores reflect
greater fear, worry or concern. Missing items (nearly al-
ways the likelihood of recurrence question) were replaced
with the mean of the participant’s other items.
Distress level and impact of distress were assessed
from a modified 2-item distress thermometer [48] which
asked participants to rate their level of distress over the
past week from 0 (least distress) to 10 (most distress)
and the impact of that distress on doing day-to-day ac-
tivities from 0 (no impact) to 10 (highest impact).
Participant satisfaction was assessed with regard to the
program overall, the coaching calls, and the program
workbook, using a 5-point Likert scale.
Sample size
As described in detail elsewhere [36], the sample size
was chosen a priori to provide at least 90% power (with
two-tailed significance of p < 0.001) to detect minimum
differences of interest in body weight (2 kg), moderate-
vigorous physical activity (60 min/week), fruit (0.5
serves), vegetables (0.5 serves), and physical and mental
quality of life (3 units).
Statistical analyses
Analyses were performed in IBM SPSS Statistics for
Windows 24.0 (IBM Corporation, Armonk NY USA).
Statistical significance was set at two-tailed p < 0.001.
Process outcomes were reported using descriptive statis-
tics as means and standard deviations or number and
percentages as appropriate. Changes over time in
patient-reported outcomes were analysed using mixed
models, including all available data from all participants
(n = 753 to 786 at baseline and n = 461 to 500 at post
intervention). Models included effects of time (baseline /
post intervention), strata (Cancer Council: A / B / C /
D), and time x Cancer Council interaction. Changes are
reported overall (pooled) and within each strata, based
on comparisons of marginal means. To assess the sensi-
tivity of conclusions to missing data, results are also re-
ported adjusted for predictors of missing data, and using
multiple imputation (m = 50 imputations). Dropout
accounted for the vast majority of missing data. For
most outcomes, predictors of missing data were treated
as variables associated with dropout at p < 0.2 with pre-
dictors of missing data assessed separately for waist cir-
cumference, fibre index scores, and fear of cancer
recurrence, which had approximately 5–10% item miss-
ing data. Imputation was by the fully conditional specifi-
cation method, with predictive mean matching.
Imputation models contained the variables in the ana-
lytic models, predictors of missing data, plus auxiliary
variables that may help predict the missing outcomes
(variables associated with the outcome at p < 0.2) (see
Additional file 2). A per protocol analysis was also per-
formed, evaluating changes in patient-reported out-
comes among program completers (i.e., those who





Five state-based Cancer Councils were approached to
take part in the study; four agreed and one declined due
to resource limitations.
Reach
Participant flow through the study is detailed in Fig. 1. In
total, 1183 cancer survivors were referred into HLaC (260
to 372 in each Cancer Council) with 886 (90.4% of those
screened) found eligible to participate. The predominant
referral pathway into the program was directly through
the Cancer Councils (callers to their telephone informa-
tion and support line, website visitors and/or users of
other Cancer Council support services; Additional file 3).
Ultimately, 786 eligible cancer survivors participated, an
uptake of 88.7% overall (84.6 to 96.6% in each Cancer
Council). Uptake did not differ significantly between refer-
ral sources or participant characteristics: age; sex; cancer
type; and, time since diagnosis (Additional file 3).
Participant characteristics are shown in Table 1, over-
all and by each state Cancer Council. Overall, partici-
pants in the HLaC program (n = 786) were mostly
women (88.0%), mostly Caucasian (89.7%), had an aver-
age (mean ± SD) age of 57.5 ± 11.4 years, BMI of 28.8 ±
6.5 kg/m2, were on average 1.9 ± 3.0 years since diagno-
sis, and many (44.3%) lived in areas with postcodes
ranked in the highest 30% for their state regarding socio-
economic position. There were some apparent differ-
ences (≥10% or p < 0.05) between the four Cancer
Councils in the sample of participants recruited. Some
variation was seen in ethnicity (4.7 to 14.5% minority),
degree of comorbidity (17.0 to 25.6% had ≥4 comorbidi-
ties), education (32.9 to 50.8% had a university educa-
tion), employment (8.3 to 20.0% unable to work),
geography (67.1 to 80.8% living in major cities),
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socioeconomic position (38.0 to 51.8% were in the mid-
dle 40% of postcodes for their state), cancer type (56.7 to
67.9% had breast cancer), receipt of hormone therapy
(36.5 to 50.0%), mean age at baseline (55.3 to 59.5 years),
and mean BMI (27.7 to 30.1 kg/m2). None of these dif-
ferences were significant at p < 0.001. At baseline, many
participants already had BMI < 25 kg/m2 (67.4%), many
met recommendations of at least two daily fruit serves
(55.1%) and 150 min/week moderate-vigorous physical
activity (49.9%), while only a small minority had a low-
risk waist circumference (14.5%; < 80 cm in women, <
94 cm in men) and few consumed at least 5 daily vege-
table serves (16.5%) (Additional file 4).
Implementation
Study retention was 63.4%, with 498 participants com-
pleting the post-program evaluation and 288 dropping
out. Program completion was 60.6% overall, with 476
participants completing ≥4 intervention calls and post-
program evaluation and varied across the Cancer Coun-
cils (66.5% [A], 67.1% [B], 35.0% [C], and 75.6% [D], p <
0.001). The remaining 310 participants (39.4%) were clas-
sified as withdrawn, predominantly because they were un-
contactable (30.3%), not interested (24.2%), too busy
(22.9%), or for personal health reasons usually involving
their cancer (18.7%), with a small number withdrawing for
other reasons including family illness (3.9%). Differences
between those who completed the program or withdrew
were non-significant (p ≥ 0.001) and also mostly small
(Additional file 5), with some minor tendencies for pro-
gram completers (relative to their counterparts) to be
older, from an English speaking background, have breast
as opposed to other forms of cancer, have higher baseline
fruit and vegetable intakes, and better mental quality of
life. Program completers received a median of 11 calls
(from 4 to 17) compared with 3 (0 to 13) calls among
withdrawals. Mean (±SD) intervention call duration was
30.6 ± 10.6min across the 4687 delivered calls whose dur-
ation was recorded. No serious adverse events related to
the intervention were reported.
Costs
Program delivery costs were estimated at AU$504,
980 (US$349,709) for the 1183 referred cancer sur-
vivors, equating to a mean cost of AU$427
(US$296) per referred cancer survivor (Additional
file 1). The mean cost was AU$85 (US$59) per in-
eligible cancer survivor or whose eligibility we
could not determine (n = 297), AU$388 (US$269)
per partial program completer / did not commence
the program (n = 410), and AU$673 (US$466) per
program completer (n = 476).
Maintenance
At the time of writing, each of the four HLaC participat-
ing Cancer Councils were considering HLaC results and
delivery costs to inform decisions about whether or how
they might continue to offer the program. During the
study, the majority of program delivery was funded by
the study grant. However, following the study, delivery
costs would be fully borne by each Cancer Council. One
Cancer Council was in the process of adapting the pro-
gram for web-based delivery and two were going to con-
tinue to offer it at a reduced scale and as a means of
promoting maintenance among cancer survivors com-
pleting their existing exercise classes.
Secondary outcomes
Effectiveness
All of the patient-reported outcomes improved signifi-
cantly over time (Table 2) and did not significantly differ
between the Cancer Councils. Overall, average changes
were − 2.24 kg body weight (95% CI: − 2.61, − 1.88),
equivalent to − 0.80 kg/m2 BMI (95% CI: − 0.93, − 0.67).
These corresponded with substantial improvements in
self-reported MVPA (148 min/week, 95% CI: 125, 171),
reduced sitting time (− 1.19 h/day, 95% CI: − 1.42, −
0.96), and small (0.2 to < 0.5 SD) to moderate (0.5 to <
0.8 SD) improvements in dietary outcomes: an increase
of 0.99 vegetable serves/day (95% CI: 0.83, 1.16); 0.28
fruit serves/day (95% CI: 0.29, 0.36); 0.32 units on the
dietary fat index (95% CI: 0.29, 0.36); and, 0.24 units on
the dietary fibre index (95% CI: 0.19, 0.28). There were
also sizeable improvements (> 0.5 SD) in physical quality
of life (6.10 units, 95% CI: 5.21, 7.00), symptom severity
(− 1.00 units, 95% CI: − 1.12, − 0.87) and symptom inter-
ference (− 1.36 units, 95% CI: − 1.53, − 1.18). There were
also small improvements (0.2 to < 0.5 SD) in psycho-
social outcomes: mental quality of life (2.66 units, 95%
CI: 1.80, 3.51); fear of cancer recurrence (− 3.36 units,
95% CI:-4.07, − 2.65); distress level (− 0.71, 95% CI: −
0.94, − 0.48); and, distress impact (− 0.68 units, 95% CI:
− 0.90, − 0.47). The degree to which these changes in
mean outcomes corresponded with increases in the pro-
portion of participants adhering to national recommen-
dations can be seen in Additional file 4.
Stratified results are shown in Additional file 6. As with
the pooled effects, the direction of the changes consist-
ently favoured improvement, though not always statisti-
cally significant or necessarily of the same magnitude.
Importantly, none of the Cancer Councils achieved stron-
ger or weaker results across all or most outcomes.
Additional file 7 shows the pooled effects as estimated
from all participants (multiple imputation analysis), in
evaluable cases with adjustment for predictors of drop-
out, and in those who adhered to the program protocol
(i.e., program completers). Conclusions were mostly
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robust to missing data handling, with all of the outcomes
improving significantly and to a similar extent: most
were identical to within ±10% in multiply imputed and
dropout-adjusted models relative to what was seen in
the main analyses. Improvements in fruit intake were
≈14% smaller (0.04 serves) in both sensitivity analyses; im-
provements in distress were ≈13% lower with adjustment
for predictors of dropout (0.09 units), and improvement in
mental quality of life were ≈12% lower with adjustment
for predictors of dropout (0.30 units). The per protocol
analysis showed similar results in those who adhered to
the protocol (i.e., were program completers) to those seen
in all evaluated participants. All outcomes improved sig-
nificantly, to a similar degree as in the main evaluation
(most were identical to within ±10%, with the largest dif-
ference in results being for distress impact (≈19% smaller
improvement in program completers than overall). Per-
protocol results within each Cancer Council are shown in
Additional file 8. As with the main evaluation, these
showed all outcomes tended towards improvement in
every Cancer Council (not always statistically significant),
and with some potentially sizable (but not statistically sig-
nificant) differences between the Cancer Councils.
Participant satisfaction
Figure 2 shows participant satisfaction with the program,
coaching calls and resources. Overall, satisfaction was
very high with 77.7, 81.5 and 62.9% reporting the highest
satisfaction rating “very satisfied” for these aspects of the
HLaC Program, respectively.
Discussion
The Healthy Living after Cancer program was taken up
by four of five state-based Australian Cancer Councils,
delivered to 786 (≈89%) eligible referred cancer survi-
vors, most of whom (80%) received the minimum de-
sired health coaching and many of whom (60%)
completed the program. While some of the primary out-
comes (especially completion rates) varied between the
Cancer Councils, effectiveness of the program was dem-
onstrated by all participating Cancer Councils. The pro-
gram was significantly effective for all of the participant-
reported outcomes. Improvements in body anthropom-
etry (e.g., ≈2 kg weight loss) occurred alongside sizeable
increases in physical activity and modest improvements
in dietary indicators, with corresponding sizeable im-
provements in physical quality of life and symptoms,
and smaller improvements in mental quality of life and
other psychosocial outcomes.
Direct comparators for HLaC primary outcomes of
reach and implementation are few, as there are no pub-
lished reports of health behaviour interventions for can-
cer survivors delivered via distance modalities and at
scale by health professional staff in a health service
Table 2 Baseline to post-program changes in patient reported outcomes in all Healthy Living after Cancer participants










Weight, kg 78.9 ± 18.8 786 494 −2.24 (−2.61, −1.88) < 0.001 0.057
Body Mass Index, kg/m2 28.8 ± 6.5 786 494 −0.80 (−0.93, −0.67) < 0.001 0.081
Waist circumference, cm 97.6 ± 15.3 781 477 −4.42 (−5.08, −3.77) < 0.001 0.063
MVPA, min/week 207.4 ± 210.2 786 498 147.64 (124.25, 171.03) < 0.001 0.334
Sitting on weekdays, h/day 6.5 ± 3 782 498 −1.19 (− 1.42, −0.96) < 0.001 0.755
Vegetables, serves/day 3.0 ± 1.8 786 498 0.99 (0.83, 1.16) < 0.001 0.111
Fruit, serves/day 1.8 ± 1.1 785 498 0.28 (0.19, 0.36) < 0.001 0.074
Fat Index, 1–5 3.1 ± 0.5 771 489 0.32 (0.29, 0.36) < 0.001 0.255
Fibre Index, 1–5 2.8 ± 0.5 753 461 0.24 (0.19, 0.28) < 0.001 0.290
Physical Quality of life, 0–100 39.7 ± 10.2 786 500 6.10 (5.21, 7.00) < 0.001 0.277
Mental Quality of life, 0–100 47.2 ± 10.7 786 500 2.66 (1.80, 3.51) < 0.001 0.184
Symptom Severity, 0–10 4.1 ± 1.8 786 499 −1.00 (−1.12, −0.87) < 0.001 0.655
Symptom Interference, 0–10 3.9 ± 2.4 785 499 −1.36 (− 1.53, − 1.18) < 0.001 0.687
Fear of cancer recurrence, 0–40 16.5 ± 10.4 786 499 −3.36 (−4.07, −2.65) < 0.001 0.503
Distress Level, 0–10 2.9 ± 2.7 784 497 −0.71 (− 0.94, − 0.48) < 0.001 0.891
Distress Impact, 0–10 2.2 ± 2.8 784 497 −0.68 (− 0.90, − 0.47) < 0.001 0.402
MVPA moderate-vigorous physical activity, CI confidence interval
a Pooled mean change estimated by comparison of marginal means for the effect of time (baseline / post program), estimated balanced across strata (cancer
council: A, B, C, D) from model that includes effects of time, cancer council, and their two-way interaction
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setting. Indeed, retention rates in implementation or
real-world contexts are typically lower than that ob-
served in controlled trials. The most comparable pro-
gram is the Australian Get Healthy Information and
Coaching Service [49, 50]. Like HLaC, the Get Healthy
Service is a six-month telephone health coaching pro-
gram targeting physical activity, healthy eating and
healthy weight. However, it is delivered by a state health
department and targets the general adult population, pri-
marily through media-based promotion.
The Get Healthy Service reported a program comple-
tion rate of approximately 25%, substantially lower than
that achieved in HLaC (60%). This is likely due to the
significant challenge of attracting and retaining program
participants made aware of the program primarily
through advertising, rather than targeted accrual
through personal invitation. HLaC participants were
mostly those who had contacted the Cancer Council in
their state for information about cancer and its effects
and as such may have had a higher level of motivation
for program completion. Higher completion rates (44%)
were also seen in a six-month telephone health coaching
program delivered by an Australian Division of General
Practice to adults with (non-cancer) chronic conditions
and based on general practitioner referral [51], suggest-
ing the importance of more targeted forms of referral. It
may also be the case that those with a diagnosis of can-
cer are more motivated to complete health behaviour
intervention programs than the general adult population
or adults with other (non-cancer) chronic conditions.
This has been reported particularly among women with
breast cancer, with study retention rates typically 80–
90% [25, 52], noting that the majority of HLaC partici-
pants were women with breast cancer.
In terms of secondary effectiveness outcomes, mean
weight loss observed in HLaC is less than what was ob-
served in our precursor randomised controlled effective-
ness trials in women with breast cancer [53] and other
similar telephone-delivered breast cancer weight loss tri-
als [54]. However, this is consistent with the attenuation
of intervention effect sizes when intervention evaluation
occurs in efficacy, effectiveness and dissemination con-
texts [55]. Evidence suggests that weight losses of 7–10%
of body weight are likely needed to reduce risk of co-
morbidities and mortality [56], although benefit may be
seen with weight loss as little as 3% [57]. Thus the mag-
nitude of weight loss observed in HLaC is likely to im-
part some health benefit, particularly on a population
level, given the scalable nature of the intervention, and
the detrimental effects of this weight gain on both can-
cer and general health outcomes [58].
HLaC mean costs are considered to be relatively low
when taking into account the improvements observed in
weight management, physical activity and diet. They are
in line with the limited reporting of intervention delivery
costs in cancer survivor populations [28, 59] and similar
to costs reported in the Get Healthy Service evaluation
described below [49].
In comparison to HLaC effectiveness outcomes, weight,
waist circumference and dietary outcomes (the only ones
directly comparable with Get Healthy Service reporting
and based on participant self-report), Get Healthy
Fig. 2 Participant satisfaction with the Healty Living after Cancer program
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Service outcomes are marginally superior for weight and
waist circumference (− 3.8 kg and − 5.1 cm, respectively),
but similar for vegetable and fruit serves (+ 1.2 and + 0.4
serves, respectively; GHS evaluation report) [50]. Greater
decreases in weight and waist circumference may be due
to the higher levels of the Get Healthy Service sample at
baseline and perhaps also owing to the selected sample
of program completers.
Lawler and colleagues, in a pre-post pilot study, of-
fered the Get Healthy Service to 53 women with stage I-
III breast cancer following treatment and on referral by
cancer nurses in an Australian breast cancer clinic [60].
Here, among program completers, results for program
completion and self-reported weight were similar to
HLaC (62% and − 2.4 kg, respectively), increases in mi-
nutes per week of MVPA were less (+ 55min) and no in-
crease in serves of vegetables or fruit were observed. The
increase in weekly MVPA observed in HLaC (+ 148 min)
is particularly notable, as it is consistent with a magni-
tude of benefit shown in epidemiologic studies to confer
a significant reduction in cancer mortality [61].
The primary strength of the study was the partnership
context in which it was conducted. This included work-
ing closely with the Cancer Councils to integrate the
intervention into their Cancer Information and Support
Service to achieve delivery at scale. It also afforded op-
portunity to build capacity amongst Cancer Council staff
in lifestyle intervention implementation and program
evaluation. Making the program widely available across
the diverse population of cancer survivors was also a
strength. The generalisability of results is limited by the
largely female, Caucasian and breast cancer survivor
sample, which does not represent the broader popula-
tion of Australian cancer survivors [2]. There are also in-
herent limitations in the use of a single group, pre-post
study design, along with the use of self-report outcome
measures. The collection of data by Cancer Council staff,
some of whom had a role in program delivery, could
have been a source of bias, but this risk is mitigated by
the robustness of findings across strata. The evaluation
of effectiveness was adequately powered overall but
lacked precision around estimated effectiveness within
each Cancer Council, as well as the comparison between
the Cancer Councils.
Conclusions
This is the first study that reports on the effectiveness
and feasibility of a scaled up and national implementa-
tion of an evidence-based, telephone-delivered, lifestyle
program for cancer survivors implemented in conjunc-
tion with a peak cancer control partner. It was designed
in response to calls for the conduct of practice-based
dissemination research that accelerates the transfer of
evidence into cancer survivorship care [62–64]. Based
on our RE-AIM findings, the intervention is considered
feasible to deliver at scale, with improvements in an-
thropometric, behavioural and psychosocial participant-
reported outcomes of a magnitude likely to reduce can-
cer morbidity and mortality in the growing number of
cancer survivors. While the costs to deliver the program
were relatively low, particularly in light of participant
benefits, all Cancer Councils indicated that the resource
implications of sustained program delivery remained a
barrier. At the time of writing, two Cancer Councils
were delivering the program on a smaller scale and one
was in the process of adapting it for online delivery. Ad-
vocacy efforts targeting funding from state and national
government health and cancer agencies, based on the
strong evidence of impact demonstrated in this dissem-
ination study, will likely be required to support contin-
ued program delivery.
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